Flunarizine is a calcium channel blocker that acts by inhibiting voltage-dependent calcium influx in neuronal cells, which may help modulate abnormal cortical hyperexcitability associated with Visual Snow Syndrome. By reducing neuronal hyperactivity and potentially stabilizing neurotransmitter release, it can potentially ameliorate visual disturbances and associated neurological symptoms in some patients with this syndrome.